Clinical Trial Update: Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing guided discontinuation versus maintenance sirolimus in pediatric Kaposiform Hemangioendothelioma and Kasabach-Merritt Syndrome has com…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kaposiform Hemangioendothelioma
• Kasabach-merritt Syndrome

Drugs mentioned

• Sirolimus (Sirolimus)

Snippet

Sponsor: Children's Hospital of Fudan University | Conditions: Kaposiform Hemangioendothelioma, Kasabach-Merritt Syndrome | Phase 4 | Status: COMPLETED